Targeting PI3K/Akt signaling in prostate cancer therapy

Abadi AJ et al (2021) Small in size, but large in action: microRNAs as potential modulators of PTEN in breast and lung cancers. Biomolecules 11(2):304

Abd Wahab NA et al (2021) Diarylpentanoid (1,5-bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadiene-3-one) (MS13) Exhibits Anti-proliferative, Apoptosis Induction and Anti-migration Properties on Androgen-independent Human Prostate Cancer by Targeting Cell Cycle-Apoptosis and PI3K Signalling Pathways. Front Pharmacol 12:707335

Abd-Rabou AA et al (2021) Thymoquinone Crosstalks with DR5 to Sensitize TRAIL Resistance and Stimulate ROS-Mediated Cancer Apoptosis. Asian Pac J Cancer Prev 22(9):2855–2865

CAS  PubMed  PubMed Central  Google Scholar 

Adelaiye-Ogala R et al (2020) Targeting the PI3K/AKT Pathway Overcomes Enzalutamide Resistance by Inhibiting Induction of the Glucocorticoid Receptor. Mol Cancer Ther 19(7):1436–1447

CAS  PubMed  PubMed Central  Google Scholar 

Akinleye A et al (2013) Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics. J Hematol Oncol 6(1):88

PubMed  PubMed Central  Google Scholar 

Alam S et al (2022) Thymoquinone and quercetin induce enhanced apoptosis in non-small cell lung cancer in combination through the Bax/Bcl2 cascade. J Cell Biochem 123(2):259–274

CAS  PubMed  Google Scholar 

Annala M et al (2018) Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer. Cancer Discov 8(4):444–457

CAS  PubMed  Google Scholar 

Arbiser JL et al (2002) Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci USA 99(2):715–720

Argiris A et al (2006) A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer. Cancer Biol Ther 5:766–770

Arora VK et al (2013) Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade. Cell 155(6):1309–1322

Ashrafizadeh M et al (2020a) Progress in delivery of siRNA-based therapeutics employing nano-vehicles for treatment of prostate cancer. Bioengineering (Basel) 7(3):91

Ashrafizadeh M et al (2020b) PTEN: What we know of the function and regulation of this onco-suppressor factor in bladder cancer? Eur J Pharmacol 881:173226

Ashrafizadeh M et al (2020c) PTEN, a barrier for proliferation and metastasis of gastric cancer cells: from molecular pathways to targeting and regulation. Biomedicines 8:264

Ashrafizadeh M et al (2020d) Association of the epithelial–mesenchymal transition (EMT) with cisplatin resistance. Int J Mol Sci 21(11):4002

Ashrafizadeh M et al (2020e) MicroRNAs and their influence on the ZEB family: mechanistic aspects and therapeutic applications in cancer therapy. Biomolecules 10(7):1040

Ashrafizadeh M et al (2021) New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities. Biomed Pharmacother 141:111824

Ashrafizadeh M et al (2022) Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response. J Exp Clin Cancer Res 41(1):105

Atmaca H, Camli Pulat C, Cittan M (2022) Liquidambar orientalis Mill. gum extract induces autophagy via PI3K/Akt/mTOR signaling pathway in prostate cancer cells. Int J Environ Health Res 32(5):1011–1019

CAS  PubMed  Google Scholar 

Ayala G et al (2004) High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence. Clin Cancer Res 10(19):6572–6578

CAS  PubMed  Google Scholar 

Bacac M, Stamenkovic I (2008) Metastatic cancer cell. Annu Rev Pathol 3:221–247

CAS  Google Scholar 

Bernstein DE et al (2021) Prostate cancer and microfluids. Urologic Oncology: Seminars and Original Investigations 39(8):455–470

CAS  PubMed  Google Scholar 

Bhattacharya S et al (2020) Delivery of thymoquinone through hyaluronic acid-decorated mixed Pluronic® nanoparticles to attenuate angiogenesis and metastasis of triple-negative breast cancer. J Control Release 322:357–374

CAS  PubMed  Google Scholar 

Bilanges B, Posor Y, Vanhaesebroeck B (2019) PI3K isoforms in cell signalling and vesicle trafficking. Nat Rev Mol Cell Biol 20(9):515–534

Bo S et al (2021) Purpurin, a anthraquinone induces ROS-mediated A549 lung cancer cell apoptosis via inhibition of PI3K/AKT and proliferation. J Pharm Pharmacol 73(8):1101–1108

PubMed  Google Scholar 

Bouali S et al (2009) PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells. Oncol Rep 21(3):731–735

CAS  PubMed  Google Scholar 

Brar SS et al (2002) An NAD (P) H oxidase regulates growth and transcription in melanoma cells. Am J Physiol Cell Physiol 282(6):C1212–C1224

Burleson M et al (2022) GLI3 Is Stabilized by SPOP Mutations and Promotes Castration Resistance via Functional Cooperation with Androgen Receptor in Prostate Cancer. Mol Cancer Res 20(1):62–76

CAS  PubMed  Google Scholar 

Cai F et al (2020) Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway. Biosci Rep 40(3):BSR20192826

Cai J et al (2021) NAT1 is a critical prognostic biomarker and inhibits proliferation of colorectal cancer through modulation of PI3K/Akt/mTOR. Future Oncol 17(19):2489–2498

CAS  PubMed  Google Scholar 

Cattrini C et al (2021) Optimal Sequencing and Predictive Biomarkers in Patients with Advanced Prostate Cancer. Cancers (Basel) 13(8):45221

Chan ML et al (2017) Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways. Oncotarget 8(57):96668–96683

PubMed  PubMed Central  Google Scholar 

Chang L et al (2013) Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance. Cell Death Dis 4(10):e875

CAS  PubMed  PubMed Central  Google Scholar 

Chang YL et al (2015) MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway. Oncotarget 6(27):24017–24031

PubMed  PubMed Central  Google Scholar 

Chang M et al (2021) Total Flavonoids of Litchi Seed Attenuate Prostate Cancer Progression Via Inhibiting AKT/mTOR and NF-kB Signaling Pathways. Front Pharmacol 12:758219

CAS  PubMed  PubMed Central  Google Scholar 

Chen H, Li H, Chen Q (2016) INPP4B reverses docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer. Biochem Biophys Res Commun 477(3):467–472

CAS  PubMed  Google Scholar 

Chen YA et al (2018) Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways. Cancers (Basel) 11(1):34

Chen X et al (2021a) EGFR and ERK activation resists flavonoid quercetin-induced anticancer activities in human cervical cancer cells in vitro. Oncol Lett 22(5):754

CAS  PubMed  PubMed Central  Google Scholar 

Chen B et al (2021b) CNTN-1 promotes docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer. Arch Med Sci 17(1):152–165

CAS  PubMed  Google Scholar 

Chen X et al (2022) Lycopene enhances the sensitivity of castration-resistant prostate cancer to enzalutamide through the AKT/EZH2/ androgen receptor signaling pathway. Biochem Biophys Res Commun 613:53–60

CAS  PubMed  Google Scholar 

Cheng TM et al (2018) Resveratrol induces sumoylated COX-2-dependent anti-proliferation in human prostate cancer LNCaP cells. Food Chem Toxicol 112:67–75

CAS  PubMed  Google Scholar 

Cheng Y et al (2021) Periplocymarin Induced Colorectal Cancer Cells Apoptosis Via Impairing PI3K/AKT Pathway. Front Oncol 11:753598

PubMed  PubMed Central  Google Scholar 

Cho HD et al (2019) Kochia scoparia seed extract suppresses VEGF-induced angiogenesis via modulating VEGF receptor 2 and PI3K/AKT/mTOR pathways. Pharm Biol 57(1):684–693

CAS  PubMed  PubMed Central  Google Scholar 

Choi SY et al (2022) SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines. Cancer Genomics Proteomics 19(1):50–59

CAS  PubMed  PubMed Central  Google Scholar 

Chu M et al (2021) Targeting cancer stem cells by nutraceuticals for cancer therapy. Semin Cancer Biol

Ci X et al (2015) KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation. Mol Cancer 14:91

PubMed  PubMed Central  Google Scholar 

Cisse O et al (2019) Downregulation of class II phosphoinositide 3-kinase PI3K-C2β delays cell division and potentiates the effect of docetaxel on cancer cell growth. J Exp Clin Cancer Res 38(1):472

CAS  PubMed  PubMed Central  Google Scholar 

Cui J et al (2021) Natural products targeting cancer stem cells: a revisit. Curr Med Chem 28(33):6773–6804

CAS  PubMed  Google Scholar 

Dai X et al (2016) Ascochlorin enhances the sensitivity of doxorubicin leading to the reversal of epithelial-to-mesenchymal transition in hepatocellular carcinoma. Mol Cancer Ther 15(12):2966–2976

Dbouk HA et al (2013) Characterization of a tumor-associated activating mutation of the p110β PI 3-kinase. PLos One 8(5):e638335

Deldar Abad Paskeh M et al (2021) Targeting Cancer Stem Cells by Dietary Agents: Important Therapeutic Strategy against Hum Malignancies. Int J Mol Sci 22(21):11669

CAS  PubMed  PubMed Central  Google Scholar 

Dickinson J et al (2016) Trends in prostate cancer incidence and mortality in Canada during the era of prostate-specific antigen screening. CMAJ Open 4(1):E73–E79

Ding X et al (2021a) Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling. Bioengineered 12(1):803–814

CAS  PubMed  PubMed Central  Google Scholar 

Ding L et al (2021b) Role of noncoding RNA in drug resistance of prostate cancer. Cell Death Dis 12(6):590

CAS  PubMed  PubMed Central  Google Scholar 

Ding Y et al (2022) Leukemia inhibitory factor receptor homodimerization mediated by acetylation of extracellular lysine promotes prostate cancer progression through the PDPK1/AKT/GCN5 axis. Clin Transl Med 12(2):e676

CAS  PubMed  PubMed Central  Google Scholar 

Dong C et al (2021) Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer. Front Pharmacol 12:628690

CAS  PubMed  PubMed Central  Google Scholar 

Duan S et al (2021) Loss of FBXO31-mediated degradation of DUSP6 dysregulates ERK and PI3K-AKT signaling and promotes prostate tumorigenesis. Cell Rep 37(3):109870

CAS  PubMed  PubMed Central  Google Scholar 

Dubrovska A et al (2009) The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci U S A 106(1):268–273

CAS  PubMed  Google Scholar 

Ehsani M et al (2022) The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2. Oncogene 41(23):3263-3277

Engelman J (2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 9(8):550–562

Erdogan S et al (2016) The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-κB signaling. Life Sci 162:77–86

CAS  PubMed  Google Scholar 

Erdogan S et al (2018) Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway. Biomed Pharmacother 107:793–805

CAS  PubMed  Google Scholar 

Fan X et al (2021) Citrate activates autophagic death of prostate cancer cells via downregulation CaMKII/AKT/mTOR pathway. Life Sci 275:119355

留言 (0)

沒有登入
gif